BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29723661)

  • 1. PML nuclear bodies: from architecture to function.
    Lallemand-Breitenbach V; de Thé H
    Curr Opin Cell Biol; 2018 Jun; 52():154-161. PubMed ID: 29723661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
    Patra U; Müller S
    Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML Nuclear bodies: the cancer connection and beyond.
    Abou-Ghali M; Lallemand-Breitenbach V
    Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
    Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
    Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
    Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
    J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review].
    Ma XF; Tan Y; Li SF; Jin W; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1696-1700. PubMed ID: 31607334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
    Chelbi-Alix MK; de Thé H
    Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
    Sahin U; de Thé H; Lallemand-Breitenbach V
    Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes.
    Udagawa O; Kato-Udagawa A; Hirano S
    Biol Open; 2022 Jun; 11(6):. PubMed ID: 35579421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.
    Salsman J; Rapkin LM; Margam NN; Duncan R; Bazett-Jones DP; Dellaire G
    Cell Death Dis; 2017 Mar; 8(3):e2724. PubMed ID: 28358373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
    Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
    Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML Body Biogenesis: A Delicate Balance of Interactions.
    Silonov SA; Smirnov EY; Kuznetsova IM; Turoverov KK; Fonin AV
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML nuclear bodies and chromatin dynamics: catch me if you can!
    Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
    Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.